{
  "PMC": "5925979",
  "DOI": "10.1111/j.1349-7006.1999.tb00658.x",
  "PMID": "10076558",
  "PMCID": "PMC5925979",
  "title": "Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.",
  "year": 1999,
  "source_url": "https://europepmc.org/article/PMC/PMC5925979",
  "source": "MED",
  "abstract_text": "Multiple endocrine neoplasia (MEN) type 2B is a clinically distinct entity among the autosomal dominant MEN 2 syndromes. Most patients with MEN 2B carry a germline mutation (M918T) of the RET proto-oncogene, while a few carry A883F. We examined a patient with MEN 2B, but without M918T or A883F, and her relatives. Here, we report the presence in this patient of 2 germline mutations, V804M and Y806C in the same allele. While the novel Y806C was inherited from her father, its carriers (her father and brother) was not affected by MEN 2. In contrast, V804M was a de novo mutation, that has been reported in patients with familial medullary thyroid carcinoma. Combinations of mutations of the RET proto-oncogene may cause oncogenic activities different from those of single mutations.",
  "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5925979 10076558 10.1111/j.1349-7006.1999.tb00658.x CAE1 Rapid Communication Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation Miyauchi Akira 1 Futami Hitoyasu 2 Hai Noritaka 4 5 Yokozawa Tamotsu 1 Kuma Kanji 1 Aoki Norihiko 5 Kosugi Shinji 4 Sugano Kokichi 3 Yamaguchi Ken 2 1 Kuma Hospital, 8‐2‐35 Shimoyamate‐dori, Chuo‐ku, Kobe 650–0011, 2 Growth Factor Division, National Cancer Center Research Institute, 3 Division of Clinical Laboratory and Medical Oncology, National Cancer Center Hospital, 5‐1‐1 Tsukiji, Chuo‐ku, Tokyo 104–0045, 4 Department of Laboratory Medicine, Kyoto University School of Medicine, 54 Kawahara‐cho, Shogoin, Sakyo‐ku, Kyoto 606–8507 and 5 Second Department of Internal Medicine, Kinki University School of Medicine, 377–2 Ohno‐Higashi, Osaka‐Sayama City, Osaka 589–0014 * To whom correspondence should be addressed. E‐mail: miyasan@gold.ocn.ne.jp 1 1999 90 1 10.1111/cas.1999.90.issue-1 1 5 Multiple endocrine neoplasia (MEN) type 2B is a clinically distinct entity among the autosomal dominant MEN 2 syndromes. Most patients with MEN 2B carry a germline mutation (M918T) of the RET proto‐oncogene, while a few carry A883F. We examined a patient with MEN 2B, but without M918T or A883F, and her relatives. Here, we report the presence in this patient of 2 germline mutations, V804M and Y806C in the same allele. While the novel Y806C was inherited from her father, its carriers (her father and brother) was not affected by MEN 2. In contrast, V804M was a de novo mutation, that has been reported in patients with familial medullary thyroid carcinoma. Combinations of mutations of the RET proto‐oncogene may cause oncogenic activities different from those of single mutations. Multiple endocrine neoplasia 2B RET proto‐oncogene Germline mutation V804M Y806C source-schema-version-number 2.0 cover-date January 1999 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 REFERENCES 1 ) Mulligan , L. M. , Marsh , D. J. , Robinson , B. G. , Schuffenecker , I. , Zedenius , J. , Lips , C. J. , Gag el , R. F. , Takai , S. I. , Noll , W. W. , Fink , M. , Raue , F. , Lacroix , A. , Thibodeau , S. N. , Frilling , A. , Ponder , B. A. J. and Eng , C. for the International RET Mutation Consortium. Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium . J. Intern. Med. , 238 , 343 – 346 ( 1995 ). 7595170 2 ) Schimke , R. N. , Hartmann , W. H. , Prout , T. W. and Rimoin , D. L. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas . N. Engl. J. Med. , 279 , 1 – 7 ( 1968 ). 4968712 3 ) Gorlin , R. J. , Sedano , H. O. , Vickers , R. A. and Cervenka , J. Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid – a syndrome . Cancer , 22 , 293 – 299 ( 1968 ). 5660196 4 ) Mulligan , L. M. and Ponder , B. A. J. Genetic basis of endocrine disease. Multiple endocrine neoplasia type 2 . J. Clin. Endocrinol. Metab. , 80 , 1989 – 1995 ( 1995 ). 7608246 5 ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Healey , C. S. , Zvelebil , M. J. , Stonehouse , T. J. , Ponder , M. A. , Jackson , C. E. , Waterfield , M. D. and Ponder , B. A. J. A novel point mutation in the tyrosine kinase domain of the RET proto‐oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC . Oncogene , 10 , 509 – 513 ( 1995 ). 7845675 6 ) Bolino , A. , Schuffenecker , I. , Luo , Y. , Seri , M. , Silengo , M. , Tocco , T. , Chabrier , G. , Houdent , C. , Murat , A. , Schlumberger , M. , Tourinaire , J. , Lenoir , G. M. and Romeo , G. RET mutations in exons 13 and 14 of FMTC patients . Oncogene , 10 , 2415 – 2419 ( 1995 ). 7784092 7 ) Fink , M. , Weinhasel , A. , Niederle , B. and Haas , O. A. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene . Int. J. Cancer , 69 , 312 – 316 ( 1996 ). 8797874 8 ) Hofstra , R. M. W. , Fattoruso , O. , Quadro , L. , Wu , Y. , Libroia , A. , Verga , U. , Colantuoni , V. and Buys , C. H. C. M. A novel point mutation in the intracellular domain of the RET protooncogene in a family with medullary thyroid carcinoma . J. Clin. Endocrinol. Metab. , 82 , 4176 – 4178 ( 1997 ). 9398735 9 ) Eng , C. , Clayton , D. , Schuffernecker , I. , Lenoir , G. , Cote , G. , Gagel , R. F. , van Amstel , H. K. , Lips , C. J. , Nishisho , I. , Takai , S. , Marsh , D. J. , Robinson , B. G. , Frank‐Raue , K. , Raue , F. , Xue , F. , Noll , W. W. , Romei , C. , Pacini , F. , Fink , M. , Niederle , B. , Zedenius , J. , Nordenskjold , M. , Komminoth , P. , Hendy , G. N. and Mulligan , L. M. The relationship between specific RET proto‐oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis . JAMA , 276 , 1575 – 1579 ( 1996 ). 8918855 10 ) Gimm , O. , Marsh , D. J. , Andrew , S. D. , Frilling , A. , Dahia , P. L. M. , Mulligan , L. M. , Zajac , J. D. , Robinson , B. G. and Eng , C. Germline dinucleotide mutation in codon 883 of the RET proto‐oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation . J. Clin. Endocrinol. Metab. , 82 , 3902 – 3904 ( 1997 ). 9360560 11 ) Smith , D. P. , Houghton , C. and Ponder , B. A. J. Germline mutation of RET codon 883 in two cases of de novo MEN 2B . Oncogene , 15 , 1213 – 1217 ( 1997 ). 9294615 12 ) Egawa , S. , Futami , H. , Takasaki , K. , Lihara , M. , Okamoto , T. , Kanbe , M. , Ohi , T. , Saio , Y. , Miyauchi , A. , Takiyama , Y. , Koga , M. , Miyanaga , K. , Inoue , K. , Mitsuyama , S. , Nomura , Y. , Takei , H. , Mugiya , S. , Ishida , O. , Zeze , F. , Shakutsui , S. , Inoue , H. , Oya , H. , Yoshimura , A. , Ishizuka , S. , Tsujino , T. , Obara , T. and Yamaguchi , K. Genotype‐phenotype correlation of the patients with multiple endocrine neoplasia type 2 in Japan . Jpn. J. Clin. Oncol. , 28 , 590 – 596 ( 1998 ). 9839497 13 ) Ceccherini , I. , Hofstra , R. M. W. , Luo , Y. , Stulp , R. P. , Barone , V. , Stelwagen , T. , Bocciardi , R. , Nijveen , H. , Bolino , A. , Seri , M. , Ronchetto , P. , Pasini , B. , Bozzano , M. , Buys , C. H. C. M. and Romeo , G. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto‐oncogene . Oncogene , 9 , 3025 – 3029 ( 1994 ). 8084609 14 ) Uchino , S. , Noguchi , S. , Adachi , M. , Sato , M. , Yamashita , H. , Watanabe , S. , Murakami , T. , Toda , M. , Murakami , N. and Yamashita , H. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 411 – 418 ( 1998 ). 9617347 15 ) Scurini , C. , Quadro , L. , Fattoruso , O. , Verga , U. , Livroia , A. , Lupoli , G. , Cascone , E. , Marzano , L. , Paracchi , S. , Bus‐nardo , B. , Girelli , M. E. , Bellastella , A. and Colantuoni , V. Germline and somatic mutations of the RET proto‐oncogene in apparently sporadic medullary thyroid carcinomas . Mol. Cell Endocrinol. , 137 , 51 – 57 ( 1998 ). 9607728 16 ) Santoro , M. , Carlomagno , F. , Romano , A. , Bottaro , D. P. , Dathan , N. A. , Grieco , M. , Fusco , A. , Vecchio , G. , Matoskova , B. , Kraus , M. H. and Fiole , P. P. D. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B . Science , 267 , 381 – 383 ( 1995 ). 7824936 17 ) Pasini , A. , Geneste , O. , Legrand , P. , Schlumberger , M. , Rossel , M. , Fournier , L. , Rudkin , B. B. , Schuffenecker , I. , Lenoir , G. M. and Billaud , M. Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain . Oncogene , 15 , 393 – 402 ( 1997 ). 9242375 18 ) Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis‐Keller , H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 91 , 1579 – 1583 ( 1994 ). 7906417 19 ) Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. J. and Robinson , B. G. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 56 , 1241 – 1243 ( 1996 ). 8640806 20 ) Miyauchi , A. , Egawa , S. , Futami , H. , Kuma , K. , Obara , T. and Yamaguchi , K. A novel somatic mutation in the RET proto‐oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation . Jpn. J. Cancer Res. , 88 , 527 – 531 ( 1997 ). 9263528",
  "plain_text": "Multiple endocrine neoplasia (MEN) type 2B is a clinically distinct entity among the autosomal dominant MEN 2 syndromes. Most patients with MEN 2B carry a germline mutation (M918T) of the RET proto‐oncogene, while a few carry A883F. We examined a patient with MEN 2B, but without M918T or A883F, and her relatives. Here, we report the presence in this patient of 2 germline mutations, V804M and Y806C in the same allele. While the novel Y806C was inherited from her father, its carriers (her father and brother) was not affected by MEN 2. In contrast, V804M was a de novo mutation, that has been reported in patients with familial medullary thyroid carcinoma. Combinations of mutations of the RET proto‐oncogene may cause oncogenic activities different from those of single mutations."
}
